News Release
- 2024.12.09 Other
- Notification regarding Investment in ReEir, Inc., Bio-venture for Regenerative Medicine and Cell Medicine Development
- 2024.11.18 Research and Development
- Notification of the Adoption of Public Solicitation for Program on R&D of New Generation Vaccine Including New Modality Application by AMED
- 2024.10.10 Research and Development
- Notification of the start of clinical development for HP-3150 (transdermal nonsteroidal pain treatment) in the U.S.
- 2024.10.10 lR Information
- Notification regarding Introduction of “Employee Shareholding Incentive Plan (E-Ship®)”
- 2024.10.10 lR Information
- FY02/2025 Q2 Results Earnings Release Presentation
- 2024.10.07 Other
- Notification of Open Innovation in SAGA Global Research Center
- 2024.07.29 lR Information
- Notice regarding Determination of Details of Issuance of Stock Compensation- Type Share Options (Stock Acquisition Rights)
- 2024.07.11 lR Information
- Notice regarding Issuance of Stock Compensation-Type Share Options (Stock Acquisition Rights)
- 2024.07.11 lR Information
- FY02/2025 Q1 Results Earnings Release Presentation
- 2024.07.01 Research and Development
- Notification of the results of the Phase II clinical study of HP-6050 in Japan
- 2024.05.24 lR Information
- Notification regarding results of repurchase of treasury shares through Off-Auction Own Share Repurchase Trading System (ToSTNeT-3)
- 2024.05.23 lR Information
- Notification regarding acquisition of treasury stock and purchasing of treasury stock through Off-Auction Own Share Repurchase Trading System(ToSTNeT-3)
- 2024.05.17 Other
- Salonpas® Named the World’s No. 1 OTC Topical Analgesic Patch Brand for the Eighth Consecutive Year
- 2024.05.16 Other
- Acquisition of DX Certification Specified by the Ministry of Economy, Trade and Industry
- 2024.04.11 Management and Personnel
- Executive Appointments
- 2024.04.11 lR Information
- FY02/2024 Q4 Results Earnings Release Presentation
- 2024.03.29 Other
- Expansion of Domestic Distribution System
- 2024.03.11 Other
- Notification of Completion of Construction of the New Research Laboratory “SAGA Global Research Center”
- 2024.02.19 Sustainability
- Notice regarding Providing Relief Supplies in Response to Disaster of the 2024 Noto Peninsula Earthquake
- 2024.02.01 Sustainability
- Notice regarding The Decision to Contribute to Supporting Organizations in FY 2023 through Hisamitsu Pharmaceutical Co., Inc. Hot Heart Club
- 2024.01.11 Sustainability
- Notice regarding Support for Disaster of the 2024 Noto Peninsula Earthquake
- 2024.01.11 lR Information
- Notice regarding Revision of Earnings Forecast
- 2024.01.11 lR Information
- FY02/2024 Q3 Results Earnings Release Presentation
